Feasibility/Acceptability of Attentional-Control Training in Survivors

This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of EndeavorRx in a cohort of survivors of acute lymphoblastic leukemia or brain tumor ages 8-16 who are \> 1 year from the end of therapy.

Trial Details

NCT ID
NCT05528939
Phase
NA
Sponsor
Children's National Research Institute
Status
RECRUITING
Cancer Type
Acute Lymphoblastic (ALL) Leukemia
Interventions
  • EndeavorRx
  • Control video game
Locations (sample)
  • Washington D.C., District of Columbia, United States|38.89511,-77.03637

Key Eligibility Criteria

  • Aged 8-16 years at time of screening.
  • History of diagnosis of acute lymphoblastic leukemia (ALL) or brain tumor (BT).
  • At least 1 year from completion of planned therapy and stable from a disease standpoint.
  • Participating child and caregiver are fluent in spoken English.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Acute Lymphoblastic (ALL) Leukemia Trials on Trialify →